Company / Return on Equity (ROE)
Embecta Corp. Return on Equity (ROE) History
FY2020-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
74.7%
FY2022
5-year range
69.8% / 74.7%
FY2020-FY2022
Trend
+7.1%
vs FY2021
Sector context
#3 of 148
Health Care
What the data says
Among 148 Health Care companies, Embecta Corp. is in the top 2% for return on equity (roe). Return on Equity (ROE) remained relatively stable over the past 3 years, with values between 69.8% and 74.7%.
Based on SEC 10-K filings.
74.7% in FY2022. Ranks 3rd among 148 companies in Health Care.
Remained stable around 74.7% over the past 2 years.
Health Care sector context is included.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
Top 2% in Health CareTop 2% of 148This company 74.7% Sector average -3.2%
▼
+2466.2% above sector average
Key checks
Key Insights
- In FY2022, return on equity (roe) increased 7.1% year-over-year.
- Currently 77.9pp above the Health Care sector average.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | 74.7% | +7.1% |
| FY2021 | 69.8% | -6.6% |
| FY2020 | 74.7% | - |
As of FY2022 · SEC 10-K · Updated Jul 2, 2026